U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
144391144391Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIVCompletedNo Results AvailableHIV InfectionsBiological: AGS-004https://ClinicalTrials.gov/show/NCT00672191
144392144392Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)TerminatedHas ResultsRenal Cell CarcinomaRadiation: Stereotactic body radiationhttps://ClinicalTrials.gov/show/NCT00672178
144393144393Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid MalignanciesCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromeBiological: ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195https://ClinicalTrials.gov/show/NCT00672165
144394144394A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following TransplantationTerminatedNo Results AvailableAcute Myelogenous Leukemia (AML)|Chronic Myelogenous Leukemia (CML)|Acute Lymphoblastic Leukemia (ALL)|Myelodysplastic Syndrome (MDS)|B Cell MalignanciesBiological: WT1 derived peptideshttps://ClinicalTrials.gov/show/NCT00672152
144395144395Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced ConstipationRecruitingNo Results AvailableOpioid-Induced ConstipationDrug: Methylnaltrexone bromidehttps://ClinicalTrials.gov/show/NCT00672139
144396144396Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With HypertensionCompletedNo Results AvailableHypertensionDrug: Adalat (Nifedipine, BAYA1040)|Drug: Coractenhttps://ClinicalTrials.gov/show/NCT00672113
144397144397Initial Local Anesthetic Dose With Continuous Interscalene AnalgesiaCompletedHas ResultsPost-operative PainDrug: Ropivacaine|Drug: Ropivacaine|Drug: Ropivacainehttps://ClinicalTrials.gov/show/NCT00672100
144398144398Diagnostic Challenges in IC (and Male CPPS)CompletedNo Results AvailableChronic Prostatitis With Chronic Pelvic Pain Syndrome|Chronic Bacterial Prostatitis|Asymptomatic Inflammatory Prostatitis|Painful Bladder Syndrome|Cystitis, InterstitialGenetic: Genomic and proteomic biomarker discoveryhttps://ClinicalTrials.gov/show/NCT00672087
144399144399Safety and Efficacy of Ipamorelin for Management of Post-Operative IleusCompletedNo Results AvailableIleusDrug: Ipamorelin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00672074
144400144400Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep ApneaCompletedNo Results AvailableSleep Apnea, ObstructiveDrug: Ramelteon or Placebohttps://ClinicalTrials.gov/show/NCT00672061
144401144401Partnership for GlaucomaCompletedNo Results AvailableGlaucomaOther: Computer Tablet|Other: Continuing Education Course|Other: Continuing educationhttps://ClinicalTrials.gov/show/NCT00672048
144402144402Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy StudyCompletedNo Results AvailableTraveler's DiarrheaBiological: Biological: heat-labile enterotoxin of E. coli (LT)https://ClinicalTrials.gov/show/NCT00672035
144403144403Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral DosesCompletedNo Results AvailableGM2 Gangliosidoses|Tay-Sachs|Sandhoff DiseaseDrug: Zavesca (Miglustat)https://ClinicalTrials.gov/show/NCT00672022
144404144404A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNo Results AvailableProstatic Diseases|Genital Neoplasms, Male|Urogenital Neoplasms|Genital Diseases, Male|Adenocarcinoma|Prostatic Neoplasms|Neoplasms, Glandular and Epithelial|CarcinomaDrug: Ixabepilonehttps://ClinicalTrials.gov/show/NCT00672009
144405144405Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' CCompletedNo Results AvailableChemotherapy|Colon CancerDrug: Mangafodipir|Drug: Placebo treatment (0.9% NaCl)https://ClinicalTrials.gov/show/NCT00671996
144406144406The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass SurgeryWithdrawnNo Results AvailableObesity|Sleep Apnea, ObstructiveProcedure: Neurocognitive Testinghttps://ClinicalTrials.gov/show/NCT00671983
144407144407Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)CompletedHas ResultsGlioblastoma|GliosarcomaDrug: Bevacizumab and Erlotinibhttps://ClinicalTrials.gov/show/NCT00671970
144408144408Energy Expenditure and Gastric Bypass Surgery StudyActive, not recruitingNo Results AvailableMorbid Obesityhttps://ClinicalTrials.gov/show/NCT00671957
144409144409Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium MetabolismCompletedNo Results AvailableOsteoporosisOther: Low protein diethttps://ClinicalTrials.gov/show/NCT00671944
144410144410Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of DexmedetomidineCompletedHas ResultsScoliosisDrug: low dexmedetomidine, low propofol|Drug: high dexmedetomidine, low propofol|Drug: Dexmedetomidine|Drug: Dexmedetomidin|Drug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT00671931
144411144411Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and MelanomaCompletedHas ResultsBreast Cancer|MelanomaDrug: Lymphoseekhttps://ClinicalTrials.gov/show/NCT00671918
144412144412Circumferential Versus Ganglionated Plexi Ablation for Atrial Fibrillation (AF)CompletedNo Results AvailableAtrial FibrillationProcedure: GP ablation|Procedure: PV isolationhttps://ClinicalTrials.gov/show/NCT00671905
144413144413Role of TLR4 in Environmental AsthmaCompletedNo Results AvailableAsthmaBiological: Lipopolysaccharide endotoxinhttps://ClinicalTrials.gov/show/NCT00671892
144414144414Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower BackCompletedHas ResultsLower Back PainDrug: Carisoprodol SR 700 mg|Drug: Carisoprodol SR 500 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00671879
144415144415Neurotoxic Health Hazards of Long-Term Low-Level Exposure to Organophosphate (OP) Compounds in in Hula ValleyNot yet recruitingNo Results AvailablePeripheral Neuropathyhttps://ClinicalTrials.gov/show/NCT00671866
144416144416Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)CompletedHas ResultsBipolar Disorder|Anxiety|Anxiety Disorders|Substance Use DisordersDrug: Quetiapine XR|Drug: Placebo for quetiapine XRhttps://ClinicalTrials.gov/show/NCT00671853
144417144417Evaluation of Robot-Assisted Surgery in Gynecologic OncologyRecruitingNo Results AvailableGynecologic CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00671827
144418144418Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy AdultsCompletedNo Results AvailableHealthy SubjectsDrug: TR-701|Drug: linezolid|Drug: placebohttps://ClinicalTrials.gov/show/NCT00671814
144419144419Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase ITerminatedNo Results AvailableMalignant GliomasDrug: Irinotecan|Drug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT00671801
144420144420A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaCompletedHas ResultsRecurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal CarcinomaDrug: Dasatinib|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00671788

* Görseller ve İçerik tekif hakkına sahip olabilir